Cited 0 times in
Post hoc analysis of pembrolizumab efficacy in potentially platinum ineligible patients with urothelial carcinoma enrolled in KEYNOTE-052 and LEAP-011
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T01:06:23Z | - |
dc.date.available | 2023-06-02T01:06:23Z | - |
dc.date.issued | 2022-09 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194657 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Post hoc analysis of pembrolizumab efficacy in potentially platinum ineligible patients with urothelial carcinoma enrolled in KEYNOTE-052 and LEAP-011 | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Y. Loriot | - |
dc.contributor.googleauthor | T. Csoszi | - |
dc.contributor.googleauthor | N. Matsubara | - |
dc.contributor.googleauthor | S.J. Shin | - |
dc.contributor.googleauthor | S.H. Park | - |
dc.contributor.googleauthor | V. Atduev | - |
dc.contributor.googleauthor | M. Gumus | - |
dc.contributor.googleauthor | B.B. Karaca | - |
dc.contributor.googleauthor | P. Grivas | - |
dc.contributor.googleauthor | R. De Wit | - |
dc.contributor.googleauthor | A.O. Siefker-Radtke | - |
dc.contributor.googleauthor | D.E. Castellano Gauna | - |
dc.contributor.googleauthor | P.H. O'Donnell | - |
dc.contributor.googleauthor | T.B. Powles | - |
dc.contributor.googleauthor | J. Vuky | - |
dc.contributor.googleauthor | Y. Zhao | - |
dc.contributor.googleauthor | K. O'hara | - |
dc.contributor.googleauthor | S. Franco | - |
dc.contributor.googleauthor | B. Homet Moreno | - |
dc.contributor.googleauthor | J. Zolnierek | - |
dc.identifier.doi | 10.1016/j.annonc.2022.07.1830 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422008080 | - |
dc.citation.volume | 33 | - |
dc.citation.number | Supplement 7 | - |
dc.citation.startPage | S1339 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Supplement 7) : S1339, 2022-09 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.